Counselor attitudes toward the use of naltrexone in substance abuse treatment

A multi-level modeling approach

Amanda J. Abraham, Traci Rieckmann, Thomas McNulty, Anne E. Kovas, Paul M. Roman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Alcohol use disorders (AUDs) continue to be one of the most pervasive and costly of the substance use disorders (SUDs). Despite evidence of clinical effectiveness, adoption of medications for the treatment of AUDs is suboptimal. Low rates of AUD medication adoption have been explained by characteristics of both treatment organizations and individual counselor's attitudes and behaviors. However, few studies have simultaneously examined the impact of organizational-level and counselor-level characteristics on counselor perceptions of EBPs. To address this gap in the literature, we use data from a national sample of 1178 counselors employed in 209 privately funded treatment organizations to examine the effects of organizational and individual counselor characteristics on counselor attitudes toward tablet and injectable naltrexone. Results of hierarchical linear modeling (HLM) show that organizational characteristics (use of tablet/injectable naltrexone in the program, 12-step orientation) were associated with counselor perceptions of naltrexone. Net of organizational characteristics, several counselor level characteristics were associated with attitudes toward tablet and injectable naltrexone including gender, tenure in the field, recovery status, percentage of AUD patients, and receipt of medication-specific training. These findings reveal that counselor receptiveness toward naltrexone is shaped in part by the organizational context in which counselors are embedded.

Original languageEnglish (US)
Pages (from-to)576-583
Number of pages8
JournalAddictive Behaviors
Volume36
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Naltrexone
Substance-Related Disorders
Alcohols
Tablets
Therapeutics
Injections
Counselors
Recovery

Keywords

  • Alcohol use disorders
  • Injectable naltrexone
  • Multilevel modeling
  • Tablet naltrexone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Toxicology
  • Medicine (miscellaneous)

Cite this

Counselor attitudes toward the use of naltrexone in substance abuse treatment : A multi-level modeling approach. / Abraham, Amanda J.; Rieckmann, Traci; McNulty, Thomas; Kovas, Anne E.; Roman, Paul M.

In: Addictive Behaviors, Vol. 36, No. 6, 06.2011, p. 576-583.

Research output: Contribution to journalArticle

Abraham, Amanda J. ; Rieckmann, Traci ; McNulty, Thomas ; Kovas, Anne E. ; Roman, Paul M. / Counselor attitudes toward the use of naltrexone in substance abuse treatment : A multi-level modeling approach. In: Addictive Behaviors. 2011 ; Vol. 36, No. 6. pp. 576-583.
@article{a479609ecbab49fa963423caa9d18d03,
title = "Counselor attitudes toward the use of naltrexone in substance abuse treatment: A multi-level modeling approach",
abstract = "Alcohol use disorders (AUDs) continue to be one of the most pervasive and costly of the substance use disorders (SUDs). Despite evidence of clinical effectiveness, adoption of medications for the treatment of AUDs is suboptimal. Low rates of AUD medication adoption have been explained by characteristics of both treatment organizations and individual counselor's attitudes and behaviors. However, few studies have simultaneously examined the impact of organizational-level and counselor-level characteristics on counselor perceptions of EBPs. To address this gap in the literature, we use data from a national sample of 1178 counselors employed in 209 privately funded treatment organizations to examine the effects of organizational and individual counselor characteristics on counselor attitudes toward tablet and injectable naltrexone. Results of hierarchical linear modeling (HLM) show that organizational characteristics (use of tablet/injectable naltrexone in the program, 12-step orientation) were associated with counselor perceptions of naltrexone. Net of organizational characteristics, several counselor level characteristics were associated with attitudes toward tablet and injectable naltrexone including gender, tenure in the field, recovery status, percentage of AUD patients, and receipt of medication-specific training. These findings reveal that counselor receptiveness toward naltrexone is shaped in part by the organizational context in which counselors are embedded.",
keywords = "Alcohol use disorders, Injectable naltrexone, Multilevel modeling, Tablet naltrexone",
author = "Abraham, {Amanda J.} and Traci Rieckmann and Thomas McNulty and Kovas, {Anne E.} and Roman, {Paul M.}",
year = "2011",
month = "6",
doi = "10.1016/j.addbeh.2011.01.030",
language = "English (US)",
volume = "36",
pages = "576--583",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Counselor attitudes toward the use of naltrexone in substance abuse treatment

T2 - A multi-level modeling approach

AU - Abraham, Amanda J.

AU - Rieckmann, Traci

AU - McNulty, Thomas

AU - Kovas, Anne E.

AU - Roman, Paul M.

PY - 2011/6

Y1 - 2011/6

N2 - Alcohol use disorders (AUDs) continue to be one of the most pervasive and costly of the substance use disorders (SUDs). Despite evidence of clinical effectiveness, adoption of medications for the treatment of AUDs is suboptimal. Low rates of AUD medication adoption have been explained by characteristics of both treatment organizations and individual counselor's attitudes and behaviors. However, few studies have simultaneously examined the impact of organizational-level and counselor-level characteristics on counselor perceptions of EBPs. To address this gap in the literature, we use data from a national sample of 1178 counselors employed in 209 privately funded treatment organizations to examine the effects of organizational and individual counselor characteristics on counselor attitudes toward tablet and injectable naltrexone. Results of hierarchical linear modeling (HLM) show that organizational characteristics (use of tablet/injectable naltrexone in the program, 12-step orientation) were associated with counselor perceptions of naltrexone. Net of organizational characteristics, several counselor level characteristics were associated with attitudes toward tablet and injectable naltrexone including gender, tenure in the field, recovery status, percentage of AUD patients, and receipt of medication-specific training. These findings reveal that counselor receptiveness toward naltrexone is shaped in part by the organizational context in which counselors are embedded.

AB - Alcohol use disorders (AUDs) continue to be one of the most pervasive and costly of the substance use disorders (SUDs). Despite evidence of clinical effectiveness, adoption of medications for the treatment of AUDs is suboptimal. Low rates of AUD medication adoption have been explained by characteristics of both treatment organizations and individual counselor's attitudes and behaviors. However, few studies have simultaneously examined the impact of organizational-level and counselor-level characteristics on counselor perceptions of EBPs. To address this gap in the literature, we use data from a national sample of 1178 counselors employed in 209 privately funded treatment organizations to examine the effects of organizational and individual counselor characteristics on counselor attitudes toward tablet and injectable naltrexone. Results of hierarchical linear modeling (HLM) show that organizational characteristics (use of tablet/injectable naltrexone in the program, 12-step orientation) were associated with counselor perceptions of naltrexone. Net of organizational characteristics, several counselor level characteristics were associated with attitudes toward tablet and injectable naltrexone including gender, tenure in the field, recovery status, percentage of AUD patients, and receipt of medication-specific training. These findings reveal that counselor receptiveness toward naltrexone is shaped in part by the organizational context in which counselors are embedded.

KW - Alcohol use disorders

KW - Injectable naltrexone

KW - Multilevel modeling

KW - Tablet naltrexone

UR - http://www.scopus.com/inward/record.url?scp=79953162253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953162253&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2011.01.030

DO - 10.1016/j.addbeh.2011.01.030

M3 - Article

VL - 36

SP - 576

EP - 583

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

IS - 6

ER -